Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
主要作者: | Shawn, Ibna Hasan |
---|---|
其他作者: | Jamiruddin, Mohd. Raeed |
格式: | Thesis |
语言: | English |
出版: |
Brac University
2024
|
主题: | |
在线阅读: | http://hdl.handle.net/10361/23931 |
相似书籍
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
由: Chakraborty, Anupama
出版: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
由: Onanna, Kazi
出版: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
由: Rahman, Towsifur
出版: (2024) -
A review on combinatorial therapies in Melanoma
由: Ahmmed, Md. Kawsar
出版: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
由: Khandker, Tahia Anjum
出版: (2024)